Administrative Core
行政核心
基本信息
- 批准号:8997367
- 负责人:
- 金额:$ 24.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-30 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressClinicalClinical ResearchClinical TrialsCollaborationsCommunicationDoctor of PhilosophyEnrollmentEnsureExpenditureFinancial SupportGrantInstitutional PolicyLeadershipLymphomaMinorityMonitorPatientsPerformanceProcessProductivityReproduction sporesResearch PersonnelTranslational ResearchWomanWorkdata exchangeflexibilityhuman subjectmeetingsmemberprogramsresponsetranslational study
项目摘要
Administrative Core
Director: Anas Younes, MD
Co-Director: Andrew Zelenetz, MD, PhD
CORE SUMMARY
The purpose of the MSK SPORE in Lymphoma Administrative Core is to coordinate the activities of the
Projects and Cores and to provide oversight and leadership of the scientific, administrative, and fiscal aspects
of the MSK SPORE in Lymphoma. The Core will be co-directed by Drs. Anas Younes and Andrew Zelenetz.
The Core will coordinate all SPORE scientific and administrative meetings, in addition to coordinating the
communications among Projects, Cores, CEP, and DRP. The administrative Core will also coordinate the
communications with the NCI, EAB, IAB, and external collaborators to enhance both horizontal and vertical
collaborations. The Administrative Core will coordinate enrollment of patients on SPORE clinical trials, and will
ensure compliance with institutional policies to protect human subjects, and will encourage participation of
women and minorities on the proposed clinical trials. One of the major advantages of the SPORE Grant is the
flexibility it allows to review the translational research productivity of existing projects and cores and make
adjustments to further strengthen this collaborative work and/or to address new critical questions in a timely
manner. The Administrative Core will establish a process for evaluating the productivity and achievements of
the Cores, Projects, DRP and CEP proposals, and will work with the Internal and External Advisors, and the
Executive Committee to decide on discontinuing activities of lower productivity and initiating new activities in
response to important translational research opportunities.
管理的核心
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANAS YOUNES其他文献
ANAS YOUNES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANAS YOUNES', 18)}}的其他基金
UT M.D. Anderson Cancer Center Lymphoma SPORE
UT M.D. 安德森癌症中心淋巴瘤孢子
- 批准号:
7697409 - 财政年份:2009
- 资助金额:
$ 24.52万 - 项目类别:
UT M.D. Anderson Cancer Center Lymphoma SPORE
UT M.D. 安德森癌症中心淋巴瘤孢子
- 批准号:
7922023 - 财政年份:2009
- 资助金额:
$ 24.52万 - 项目类别:
Clinical Activity of MGCD-0103 in Hodgkin Lymphoma
MGCD-0103 在霍奇金淋巴瘤中的临床活性
- 批准号:
7529307 - 财政年份:2008
- 资助金额:
$ 24.52万 - 项目类别:
Clinical Activity of MGCD-0103 in Hodgkin Lymphoma
MGCD-0103 在霍奇金淋巴瘤中的临床活性
- 批准号:
7652497 - 财政年份:2008
- 资助金额:
$ 24.52万 - 项目类别:
相似海外基金
Bridging lived/living and clinical expertise to address intersectional STBBI stigma: Validating a collaboratively developed experiential eLearning intervention for clinical care providers
连接生活/生活和临床专业知识,以解决交叉 STBBI 耻辱:验证为临床护理提供者合作开发的体验式电子学习干预措施
- 批准号:
487993 - 财政年份:2023
- 资助金额:
$ 24.52万 - 项目类别:
Operating Grants
A novel, first-in-its-kind, aptamer-based LYTACs to address the unmet clinical need of diabetic wounds.
一种新型、首创、基于适体的 LYTAC,可解决糖尿病伤口未得到满足的临床需求。
- 批准号:
10063511 - 财政年份:2022
- 资助金额:
$ 24.52万 - 项目类别:
EU-Funded
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
开发、试点和传播综合临床和社会多层次决策支持平台,以解决巴尔的摩市少数民族人口健康的社会决定因素
- 批准号:
10659016 - 财政年份:2021
- 资助金额:
$ 24.52万 - 项目类别:
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
开发、试点和传播综合临床和社会多层次决策支持平台,以解决巴尔的摩市少数民族人口健康的社会决定因素
- 批准号:
10454106 - 财政年份:2021
- 资助金额:
$ 24.52万 - 项目类别:
Practical use of a novel clinical resource to address medication use during breastfeeding in the context of current practice
在当前实践的背景下,实际使用一种新颖的临床资源来解决母乳喂养期间的药物使用问题
- 批准号:
458239 - 财政年份:2021
- 资助金额:
$ 24.52万 - 项目类别:
Miscellaneous Programs
Implementing a Clinical-Community Partnered Intervention to Address Food Insecurity Among High-Risk Veterans
实施临床社区合作干预措施,解决高风险退伍军人的粮食不安全问题
- 批准号:
10237185 - 财政年份:2020
- 资助金额:
$ 24.52万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10026740 - 财政年份:2020
- 资助金额:
$ 24.52万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10237364 - 财政年份:2020
- 资助金额:
$ 24.52万 - 项目类别:
Implementing a Clinical-Community Partnered Intervention to Address Food Insecurity Among High-Risk Veterans
实施临床社区合作干预措施,解决高风险退伍军人的粮食不安全问题
- 批准号:
10535426 - 财政年份:2020
- 资助金额:
$ 24.52万 - 项目类别:
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia
扩大预先护理计划的临床试验,以解决治疗引起的低血糖高风险的老年患者的治疗强度
- 批准号:
10837668 - 财政年份:2020
- 资助金额:
$ 24.52万 - 项目类别: